Cargando…
Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy
BACKGROUND: The mechanism of tumor immune escape and progression in colorectal cancer (CRC) is widely investigated in-vitro to help understand and identify agents that might play a crucial role in response to treatment and improve the overall survival of CRC patients. Several mechanisms of immune es...
Autores principales: | Taib, Nassiba, Merhi, Maysaloun, Inchakalody, Varghese, Mestiri, Sarra, Hydrose, Shereena, Makni-Maalej, Karama, Raza, Afsheen, Sahir, Fairooz, Azizi, Fouad, Nizamuddin, Parveen B., Fernandes, Queenie, Yoosuf, Zeenath Safira K. M., Almoghrabi, Salam, Al-Zaidan, Lobna, Shablak, Alaaeldin, Uddin, Shahab, Maccalli, Cristina, Al Homsi, Mohammed Ussama, Dermime, Said |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067322/ https://www.ncbi.nlm.nih.gov/pubmed/37004094 http://dx.doi.org/10.1186/s12967-023-04073-y |
Ejemplares similares
-
Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer
por: Raza, Afsheen, et al.
Publicado: (2022) -
CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
por: Maalej, Karama Makni, et al.
Publicado: (2023) -
Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatment: a case report
por: Merhi, Maysaloun, et al.
Publicado: (2020) -
Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report
por: Merhi, Maysaloun, et al.
Publicado: (2018) -
Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot study
por: Mestiri, Sarra, et al.
Publicado: (2023)